Company Kopran Limited

Equities

KOPRAN

INE082A01010

Pharmaceuticals

Delayed Bombay S.E. 12:30:02 2024-04-16 am EDT 5-day change 1st Jan Change
263 INR +1.08% Intraday chart for Kopran Limited -6.12% +8.95%

Business Summary

Kopran Limited is an India-based integrated pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (APIs). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include anti-infective, amoxycillin, ampicillin, cloxacillin and amoxy clauv. Its non-penicillin-based finished oral dosage forms include macrolides, anti-hypertensive, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management and gastroenterology. It provides ingredients in a wide range of pharmaceutical products, such as capsules, injectables and tablets, among others. The Company's APIs products include anti-hypertensive, macrolides, neuromodulator, urological, anti-infective/anti-acne, sterile carbapenems and sterile cephalosporins.

Number of employees: 902

Sales per Business

INR in Million2022Weight2023Weight Delta
Bulk Drugs
45.8 %
2,707 56.7 % 2,522 45.8 % -6.85%
Tablet/Capsules/Liquids
45.7 %
2,022 42.3 % 2,518 45.7 % +24.52%
Other Products
8.0 %
14 0.3 % 442 8.0 % +3,175.32%
Export Incentive
0.3 %
15 0.3 % 18 0.3 % +19.32%
Scrap
0.2 %
17 0.4 % 10 0.2 % -42.17%
Others
0.0 %
1 0.0 % 0 0.0 % -37.50%

Sales per region

INR in Million2022Weight2023Weight Delta
India
28.5 %
1,261 26.6 % 1,815 28.5 % +43.91%
Rest of World
28.1 %
1,641 34.6 % 1,787 28.1 % +8.93%
South Africa
20.4 %
795 16.8 % 1,297 20.4 % +63.07%
Jordan
9.9 %
69 1.5 % 631 9.9 % +814.49%
Ethiopia
5.9 %
331 7.0 % 374 5.9 % +13.00%
United Kingdom
2.9 %
69 1.4 % 183 2.9 % +166.14%
Chile
1.2 %
108 2.3 % 76 1.2 % -30.17%
Mexico
1.0 %
17 0.4 % 61 1.0 % +255.10%
Germany
0.9 %
189 4.0 % 54 0.9 % -71.25%
Zambia
0.8 %
29 0.6 % 51 0.8 % +73.68%
Tanzania
0.5 %
185 3.9 % 31 0.5 % -83.38%
Switzerland
0.0 %
49 1.0 % 2 0.0 % -95.24%

Managers

Managers TitleAgeSince
Director of Finance/CFO - 14-09-28
Compliance Officer - 14-05-27

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 19-05-07
Chairman 82 05-06-02
Director/Board Member 69 77-06-10
Director/Board Member 50 18-05-28
Director/Board Member 41 18-05-28
Director/Board Member 73 14-09-28
Director/Board Member 66 14-09-28
Director/Board Member 57 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 48,210,605 24,429,380 ( 50.67 %) 0 50.67 %

Shareholders

NameEquities%Valuation
6,217,183 12.90 % 19 M ₹
Panorama Finvest Pvt Ltd.
7.882 %
3,800,000 7.882 % 12 M ₹
Sarvamangal Mercantile Co. Ltd.
6.021 %
2,902,951 6.021 % 9 M ₹
United Shippers Ltd.
4.563 %
2,200,000 4.563 % 7 M ₹
Somani Rajendra S /Estate Of/
3.661 %
1,764,750 3.661 % 5 M ₹
Laxminarayan Vyapaar Pvt Ltd.
1.947 %
938,432 1.947 % 3 M ₹
893,590 1.854 % 3 M ₹
871,900 1.809 % 3 M ₹
788,400 1.635 % 2 M ₹
597,075 1.238 % 2 M ₹

Company contact information

Kopran Ltd.

Parijat House 1076, Dr. E. Moses Road

400018, Mumbai

+91 22 4366 1111

http://www.kopran.com
address Kopran Limited(KOPRAN)

Group companies

NameCategory and Sector
Pharmaceuticals: Major